Correlation Engine 2.0
Clear Search sequence regions

  • ATP (2)
  • benzenesulfonates (2)
  • chimeras (3)
  • drug design (1)
  • humans (1)
  • ligands (2)
  • mice (1)
  • models molecular (1)
  • mutagenesis (2)
  • nf449 (6)
  • P2X (3)
  • P2X1 (2)
  • P2X1 receptors (2)
  • p2x4 receptor (2)
  • rats (1)
  • receptor (5)
  • suramin (4)
  • xenopus laevis (1)
  • Sizes of these terms reflect their relevance to your search.

    P2X receptor subtype-selective antagonists are promising candidates for treatment of a range of pathophysiological conditions. However, in contrast to high resolution structural understanding of agonist action in the receptors, comparatively little is known about the molecular basis of antagonist binding. We have generated chimeras and point mutations in the extracellular ligand-binding loop of the human P2X1 receptor, which is inhibited by NF449, suramin, and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate, with residues from the rat P2X4 receptor, which is insensitive to these antagonists. There was little or no effect on sensitivity to suramin and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate in chimeric P2X1/4 receptors, indicating that a significant number of residues required for binding of these antagonists are present in the P2X4 receptor. Sensitivity to the P2X1 receptor-selective antagonist NF449 was reduced by ∼60- and ∼135-fold in chimeras replacing the cysteine-rich head, and the dorsal fin region below it in the adjacent subunit, respectively. Point mutants identified the importance of four positively charged residues at the base of the cysteine-rich head and two variant residues in the dorsal fin for high affinity NF449 binding. These six residues were used as the starting area for molecular docking. The four best potential NF449-binding poses were then discriminated by correspondence with the mutagenesis data and an additional mutant to validate the binding of one lobe of NF449 within the core conserved ATP-binding pocket and the other lobes coordinated by positive charge on the cysteine-rich head region and residues in the adjacent dorsal fin. © 2015 by The American Society for Biochemistry and Molecular Biology, Inc.


    Louise K Farmer, Ralf Schmid, Richard J Evans. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP. The Journal of biological chemistry. 2015 Jan 16;290(3):1559-69

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 25425641

    View Full Text